ScoreHaematology
WHO classification-based Prognostic Scoring System for MDS (WPSS)
Classifies myelodysplastic syndrome patients into five risk groups for survival and leukaemic progression.
Updated 30 October 2026
When to use it
MDS classified by WHO 2001/2008, at diagnosis or at any time during follow-up (dynamic model).
What it needs
- WHO category
- Karyotype
- Transfusion requirement
The points for each answer and the automatic total are in the app.
How to interpret it
| Result | Interpretation |
|---|---|
| ≤ 0 | Very low risk |
| 1 | Low risk |
| 2 | Intermediate risk |
| 3–4 | High risk |
| ≥ 5 | Very high risk |
Practical tip
Regular transfusion requirement: sustained red cell transfusions, roughly at least one every 8 weeks over several months.
2 more practical tips in the app.
Reference
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
